HI
VRTX icon

Hudock Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Hudock Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-164
Closed -$47K – 737
2022
Q3 		$47K Hold
164
– – 0.02% 318
2022
Q2 		$46K Hold
164
– – 0.02% 317
2022
Q1 		$42K Hold
164
– – 0.01% 341
2021
Q4 		$36K Hold
164
– – 0.01% 364
2021
Q3 		$29K Buy
164
+100
+156% +$19.5K 0.01% 401
2021
Q2 		$12K Hold
64
– – ﹤0.01% 518
2021
Q1 		$13K Hold
64
– – ﹤0.01% 502
2020
Q4 		$15K Sell
64
-10
-14% -$2.29K ﹤0.01% 464
2020
Q3 		$20K Hold
74
– – 0.01% 382
2020
Q2 		$21K Hold
74
– – 0.01% 367
2020
Q1 		$17K Buy
+74
New +$17K 0.01% 353

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Hudock Inc's VRTX Position: Q4 2022 in Review

Hudock Inc sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 164 shares — an estimated $47K sold.

Hudock Inc first reported a position in VRTX in Q1 2020 and held it in 11 quarters. The position peaked at $47K in Q3 2022. 1,222 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

  • Hudock Inc reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 164 Vertex Pharmaceuticals shares in Q4 2022, an estimated $47K.
  • Hudock Inc first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 11 quarters.
  • Hudock Inc's Vertex Pharmaceuticals position peaked at $47K in Q3 2022.
  • 1,222 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.